Skip to content
AlternativeMed

Cannabis Medicines vs Consumer Products

How regulator-approved cannabinoid medicines differ from medical-program cannabis, hemp CBD and other consumer products, and why results from one do not carry over to another.

Content last updated . This page has not been medically reviewed.

Why this split matters

Search results often blur two very different things: prescription medicines that contain a cannabinoid, and consumer products such as flower, oils, gummies and creams. A regulator can approve a specific drug, with a defined formulation and a stated use, after reviewing trials, and FDA says approved drugs are carefully evaluated for safety, efficacy and quality. [1] That kind of review does not apply to most consumer products. This page keeps them apart. It explains what regulators said, and does not tell anyone what to take or stop taking. Anyone using a prescribed medicine should talk with the prescriber before changing anything.

Evidence labels used here: approved medicine (a regulator has approved a specific drug for a stated use), marketing claim, and insufficient evidence. "Proper evidence not found" means we looked and found nothing usable.

Approved medicines (US FDA, read 2026-10-22)

The FDA says it has not approved a marketing application for cannabis for the treatment of any disease or condition. It has approved one cannabis-derived and three cannabis-related drug products, available only by prescription. [1]
MedicineWhat it containsApproved use per FDA or NCCIHSource
EpidiolexPurified plant-derived CBDSeizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex[1][2]
Marinol, SyndrosDronabinol (synthetic delta-9 THC)Per NCCIH, dronabinol is used for nausea and vomiting from cancer chemotherapy and for loss of appetite and weight loss in HIV/AIDS[1][3]
CesametNabilone (synthetic, similar to THC)Per NCCIH, nabilone is used for nausea and vomiting from cancer chemotherapy[1][3]

The label for the CBD medicine lists common adverse reactions including somnolence, decreased appetite, diarrhea, transaminase (liver enzyme) elevations and fatigue. [2] Details of each approved drug are on Approved Cannabinoid Medicines.

Approved medicines elsewhere

In the European Union, the EMA's overview for Epidyolex says it is used with clobazam for Lennox-Gastaut or Dravet syndrome, and for tuberous sclerosis complex, and that it carries a risk of liver problems. [4] NCCIH also says nabiximols (a mouth spray containing THC and CBD) is approved in more than 25 countries outside the United States but not in the US. [3] Other countries' regulators are not summarized here because we did not read their pages this session.

Medical-program cannabis is not the same as an approved medicine

NIDA says the FDA has not approved any product containing whole cannabis plant material for any purpose, even though such products are marketed for therapeutic uses and are available in many states from medical cannabis dispensaries. [5] "Medical" in a state program is a legal category. It does not mean the FDA has reviewed that product. See Medical vs Adult-Use Cannabis. This is not legal advice.

Consumer products (hemp CBD, edibles, oils, creams)

  • Not evaluated like drugs. FDA says unapproved CBD products have not been evaluated for whether they are effective for a particular disease, what dosage is proper, or how they could interact with other drugs. [6]
  • Quality varies. FDA says it tested some products and many did not contain the levels of CBD they claimed. [6] NCCIH says over-the-counter CBD products may contain more or less CBD than labeled and may contain contaminants such as THC. [3]
  • Food and supplement rules. On a page current as of March 2020 and read 2026-10-22, FDA says it is currently illegal under federal law to market CBD by adding it to a food or labeling it as a dietary supplement. [6] Laws change, and this is not legal advice. See Food vs Medicine vs Supplement and Consumer CBD Products: How They Are Regulated.
  • Claims. FDA has warned companies about unproven claims that CBD products treat serious diseases. [6] Treat such claims as marketing claims.

Results do not transfer

A trial of a purified, regulated medicine tells you about that medicine at the studied amounts in the studied people. It does not show that flower, an oil or a gummy has the same effect. NCCIH makes a similar distinction, contrasting the approved purified CBD product with over-the-counter products. [3] Evidence for conditions such as pain or sleep is summarized on Cannabis and Cannabinoid Clinical Research. Whether a given consumer product helps a condition: insufficient evidence unless a page for that condition says otherwise.

Safety note

Cannabinoid medicines and consumer products can interact with other medicines. FDA says information from studies of the approved CBD drug shows CBD can affect, and be affected by, other medicines. [6] See CBD and Medication Interactions and talk with a prescriber or pharmacist. If a child may have swallowed any cannabis product, FDA says to go to a physician or emergency department. [1] In the US, call 911 or Poison Help at 1-800-222-1222.

Frequently asked questions

Is medical cannabis the same as a prescription medicine?

Not necessarily. NIDA says FDA has not approved any whole-plant cannabis product for any purpose, though medical programs exist in many states. [5]

Is Epidiolex the same as CBD oil?

No. Epidiolex is a purified CBD prescription drug approved for specific seizure conditions; [1] over-the-counter products may contain different amounts than labeled. [3]

Has the FDA approved any cannabis-based drugs?

Yes: Epidiolex (CBD), Marinol and Syndros (dronabinol) and Cesamet (nabilone). [1]

Can a consumer CBD product replace a prescribed medicine?

That is a question for the prescriber. FDA says unapproved CBD products have not been evaluated for effectiveness against a disease. [6]

Do hemp CBD and "marijuana" products fall under the same rules?

Not exactly. Rules depend on the product, its THC content and the jurisdiction. See Hemp vs Marijuana.

References

  1. US Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD): Questions and Answers. FDA page states content current as of 07/16/2024. Read 2026-10-22.
  2. US National Library of Medicine, DailyMed. EPIDIOLEX (cannabidiol) solution, prescribing information. Label text read 2026-10-22.
  3. National Center for Complementary and Integrative Health (NCCIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know. Read 2026-10-22.
  4. European Medicines Agency. Epidyolex: EPAR medicine overview. Read 2026-10-22.
  5. National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts. Read 2026-10-22.
  6. US Food and Drug Administration. What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. FDA page states content current as of 03/05/2020. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.